{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:00:40Z","timestamp":1778097640181,"version":"3.51.4"},"reference-count":47,"publisher":"Keio Journal of Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med.","Keio j. med"],"published-print":{"date-parts":[[2023]]},"DOI":"10.2302\/kjm.2022-0036-ir","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T22:51:33Z","timestamp":1692658293000},"page":"95-101","source":"Crossref","is-referenced-by-count":7,"title":["Current Management of Chronic Constipation in Japan"],"prefix":"10.2302","volume":"72","author":[{"given":"Tatsuhiro","family":"Masaoka","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, International University              of Health and Welfare Mita Hospital, Tokyo, Japan"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal              Medicine, Keio University School of Medicine, Tokyo,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bharucha AE, Lacy BE: Mechanisms, evaluation, and          management of chronic constipation. Gastroenterology 2020; 158: 1232\u20131249. PMID:31945360          https:\/\/doi.org\/10.1053\/j.gastro.2019.12.034","DOI":"10.1053\/j.gastro.2019.12.034"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Remes-Troche JM, Coss-Adame E, Amieva-Balmori M,          Velarde-Ruiz Velasco JA, G\u00f3mez-Casta\u00f1os PC, Flores-Rend\u00f3n R, G\u00f3mez-Escudero O,          Rodr\u00edguez-Leal MC, Dur\u00e1n-Rosas C, Pinto-G\u00e1lvez SM, Priego-Parra BA, Triana-Romero A:          Incidence of \u2018new-onset\u2019 constipation and associated factors during lockdown due to the          COVID-19 pandemic. BMJ Open Gastroenterol 2021; 8: e000729. PMID:34531245          https:\/\/doi.org\/10.1136\/bmjgast-2021-000729","DOI":"10.1136\/bmjgast-2021-000729"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tomita T, Kazumori K, Baba K, Zhao X, Chen Y,          Miwa H: Impact of chronic constipation on health\u2010related quality of life and work          productivity in Japan. J Gastroenterol Hepatol 2021; 36: 1529\u20131537. PMID:33047825          https:\/\/doi.org\/10.1111\/jgh.15295","DOI":"10.1111\/jgh.15295"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chang JY, Locke RG, McNally MA, Halder SL,          Schleck CD, Zinsmeister AR, Talley NJ: Impact of functional gastrointestinal disorders on          survival in the community. Am J Gastroenterol 2010; 105: 822\u2013832. PMID:20160713          https:\/\/doi.org\/10.1038\/ajg.2010.40","DOI":"10.1038\/ajg.2010.40"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Watanabe T, Nakaya N, Kurashima K, Kuriyama S,          Tsubono Y, Tsuji I: Constipation, laxative use and risk of colorectal cancer: the Miyagi          cohort study. Eur J Cancer 2004; 40: 2109\u20132115. PMID:15341986          https:\/\/doi.org\/10.1016\/j.ejca.2004.06.014","DOI":"10.1016\/j.ejca.2004.06.014"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Honkura K, Tomata Y, Sugiyama K, Kaiho Y,          Watanabe T, Zhang S, Sugawara Y, Tsuji I: Defecation frequency and cardiovascular disease          mortality in Japan: the Ohsaki cohort study. Atherosclerosis 2016; 246: 251\u2013256.          PMID:26812003 https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.007","DOI":"10.1016\/j.atherosclerosis.2016.01.007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ishiyama Y, Hoshide S, Kanegae H, Kario K: Impact          of home blood pressure variability on cardiovascular outcome in patients with arterial          stiffness: results of the J\u2010HOP study. J Clin Hypertens (Greenwich) 2021; 23: 1529\u20131537.          PMID:34288371 https:\/\/doi.org\/10.1111\/jch.14327","DOI":"10.1111\/jch.14327"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Higgins PD, Johanson JF: Epidemiology of          constipation in North America: a systematic review. Am J Gastroenterol 2004; 99: 750\u2013759.          PMID:15089911 https:\/\/doi.org\/10.1111\/j.1572-0241.2004.04114.x","DOI":"10.1111\/j.1572-0241.2004.04114.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bernard CE , Gibbons SJ , Gomez-Pinilla PJ ,          Lurken MS , Schmalz PF , Roeder JL , Linden D , Cima RR , Dozois EJ , Larson DW ,          Camilleri M , Zinsmeister AR , Pozo MJ , Hicks GA , Farrugia Effect of age on the enteric          nervous system of the human colon. Neurogastroenterol Motil 2009; 21: 746\u2013e46.          PMID:19220755 https:\/\/doi.org\/10.1111\/j.1365-2982.2008.01245.x","DOI":"10.1111\/j.1365-2982.2008.01245.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Baidoo N, Sanger GJ, Belai A: Effect of old age          on the subpopulations of enteric glial cells in human descending colon. Glia 2023; 71:          305\u2013316. PMID:36128665 PMID:36128665https:\/\/doi.org\/10.1002\/glia.24272","DOI":"10.1002\/glia.24272"},{"key":"11","unstructured":"11.Research Society for the Diagnosis and          Treatment of Chronic Constipation: Evidence-based clinical practice guidelines for chronic          constipation 2017 [in Japanese]. Tokyo: Japanese Society of Gastroenterology, Nankodo,          2017."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vriesman MH, Koppen IJ, Camilleri M, Di Lorenzo          C, Benninga MA: Management of functional constipation in children and adults. Nat Rev          Gastroenterol Hepatol 2020; 17: 21\u201339. PMID:31690829          https:\/\/doi.org\/10.1038\/s41575-019-0222-y","DOI":"10.1038\/s41575-019-0222-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lewis SJ, Heaton KW: Stool form scale as a useful          guide to intestinal transit time. Scand J Gastroenterol 1997; 32: 920\u2013924. PMID:9299672          https:\/\/doi.org\/10.3109\/00365529709011203","DOI":"10.3109\/00365529709011203"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Longstreth GF, Thompson WG, Chey WD, Houghton LA,          Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology 2006; 130: 1480\u20131491.          PMID:16678561 https:\/\/doi.org\/10.1053\/j.gastro.2005.11.061","DOI":"10.1053\/j.gastro.2005.11.061"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ,          Simren M, Spiller R: Bowel disorders. Gastroenterology 2016; 150: 1393\u20131407. PMID:27144627          PMID:27144627https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031","DOI":"10.1053\/j.gastro.2016.02.031"},{"key":"16","unstructured":"16. Ghoshal UC, Gupta D, Kumar A, Misra A: Colonic          transit study by radio-opaque markers to investigate constipation: validation of a new          protocol for a population with rapid gut transit. Natl Med J India 2007; 20: 225\u2013229.          PMID:18254516"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Leech SC, McHugh K, Sullivan PB: Evaluation of a          method of assessing faecal loading on plain abdominal radiographs in children. Pediatr          Radiol 1999; 29: 255\u2013258. PMID:10199902          https:\/\/doi.org\/10.1007\/s002470050583","DOI":"10.1007\/s002470050583"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cangemi DJ, Flanagan R, Barshop K, Kuo B, Staller          K: Colonic stool burden a useful surrogate for slow transit constipation as determined by          a radiopaque transit study. Am J Gastroenterol 2019; 114: 519\u2013523. PMID:30730352          https:\/\/doi.org\/10.14309\/ajg.0000000000000149","DOI":"10.14309\/ajg.0000000000000149"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mizukami T, Sugimoto S, Masaoka T, Suzuki H,          Kanai T: Colonic dysmotility and morphological abnormality frequently detected in Japanese          patients with irritable bowel syndrome. Intest Res 2017; 15: 236\u2013243. PMID:28522955          https:\/\/doi.org\/10.5217\/ir.2017.15.2.236","DOI":"10.5217\/ir.2017.15.2.236"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Palsson OS, Whitehead WE, van Tilburg MA, Chang          L, Chey W, Crowell MD, Keefer L, Lembo AJ, Parkman HP, Rao SS, Sperber A, Spiegel B, Tack          J, Vanner S, Walker LS, Whorwell P, Yang Y: Development and validation of the Rome IV          diagnostic questionnaire for adults. Gastroenterology 2016; 150: 1481\u20131491.          https:\/\/doi.org\/10.1053\/j.gastro.2016.02.014","DOI":"10.1053\/j.gastro.2016.02.014"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nakajima S, Takahashi K, Sato J, Fukuda M,          Yamamoto K, Inoue T, Okumura Y, Fujiyama Y: Spectra of functional gastrointestinal          disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office          and the impact of overlapping. J Gastroenterol Hepatol 2010; 25: S138\u2013S143. PMID:20586856          https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06244.x","DOI":"10.1111\/j.1440-1746.2010.06244.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ogasawara N, Funaki Y, Kasugai K, Ebi M, Tamura          Y, Izawa S, Sasaki M: Overlap between constipation and gastroesophageal reflux disease in          Japan: results from an internet survey. J Neurogastroenterol Motil 2022; 28: 291\u2013302.          PMID:34801991 https:\/\/doi.org\/10.5056\/jnm21065","DOI":"10.5056\/jnm21065"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Park KS, Jee SR, Lee BE, Hong KS, Shin JE, Na SY,          Kwon JG, Choi SC, Kim YS, Lee HS, Lee TH, Kim KO, Choi J, Moon HS, Kim YS, Park MI, Park          SJ, Park SY, Hong SN, Constipation Research Group of Korean Society of          Neurogastroenterology and Motility: Nationwide multicenter study for overlaps of common          functional gastrointestinal disorders in Korean patients with constipation. J          Neurogastroenterol Motil 2017; 23: 569\u2013577. PMID:28992677          https:\/\/doi.org\/10.5056\/jnm17033","DOI":"10.5056\/jnm17033"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ueki T, Nagai K, Mizukami Y, Takahashi A, Ooe N,          Nakashima MN, Nishida K, Nakamura J, Nakashima M: Cross-sectional study on relationship          between constipation and medication in consideration of sleep disorder. Yakugaku Zasshi          2011; 131: 1225\u20131232. PMID:21804327          https:\/\/doi.org\/10.1248\/yakushi.131.1225","DOI":"10.1248\/yakushi.131.1225"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nakaji S, Tokunaga S, Sakamoto J, Todate M,          Shimoyama T, Umeda T, Sugawara K: Relationship between lifestyle factors and defecation in          a Japanese population. Eur J Nutr 2002; 41: 244\u2013248. PMID:12474067          https:\/\/doi.org\/10.1007\/s00394-002-0380-4","DOI":"10.1007\/s00394-002-0380-4"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. L\u00e4m\u00e5s K, Lindholm L, Stenlund H, Engstr\u00f6m B,          Jacobsson C: Effects of abdominal massage in management of constipation\u2014a randomized          controlled trial. Int J Nurs Stud 2009; 46: 759\u2013767. PMID:19217105          https:\/\/doi.org\/10.1016\/j.ijnurstu.2009.01.007","DOI":"10.1016\/j.ijnurstu.2009.01.007"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Veith I: Physican travelers in Japan (Engelbert          Kaempfer, Karl Peter Thunberg, Philipp Franz Von Siebold). JAMA 1965; 192: 137\u2013140.          PMID:14263525 https:\/\/doi.org\/10.1001\/jama.1965.03080150067016","DOI":"10.1001\/jama.1965.03080150067016"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mori H, Tack J, Suzuki H: Magnesium oxide in          constipation. Nutrients 2021; 13: 421. PMID:33525523          https:\/\/doi.org\/10.3390\/nu13020421","DOI":"10.3390\/nu13020421"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Morishita D, Tomita T, Mori S, Kimura T, Oshima          T, Fukui H, Miwa H: Senna versus magnesium oxide for the treatment of chronic          constipation: a randomized, placebo-controlled trial. Am J Gastroenterol 2021; 116:          152\u2013161. PMID:32969946 https:\/\/doi.org\/10.14309\/ajg.0000000000000942","DOI":"10.14309\/ajg.0000000000000942"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Passos MC, Takemoto ML, Corradino GC, Guedes LS:          Systematic review with meta-analysis: lubiprostone efficacy on the treatment of patients          with constipation. Arq Gastroenterol 2020; 57: 498\u2013506. PMID:33331483          https:\/\/doi.org\/10.1590\/s0004-2803.202000000-83","DOI":"10.1590\/s0004-2803.202000000-83"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Eguchi T, Yoshizaki T, Takagi M, Ikeoka S,          Hashimura H, Okamoto N, Matsumoto M, Matsuda T, Miura T, Momose K, Otsuka T, Morisawa T,          Okada A: Risk factors for adverse events in patients with chronic constipation following          lubiprostone administration. Dig Dis 2021; 39: 10\u201315. PMID:32450563          https:\/\/doi.org\/10.1159\/000508864","DOI":"10.1159\/000508864"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ohbayashi H, Sato Y, Kiuchi M, Nagazumi A, Kanzo          T, Kimura T: Analysis of the impact on efficacy of lubiprostone dose reduction to manage          adverse events in the treatment of chronic constipation in Japan. Expert Rev Gastroenterol          Hepatol 2022; 16: 809\u2013817. PMID:35993999          https:\/\/doi.org\/10.1080\/17474124.2022.2114455","DOI":"10.1080\/17474124.2022.2114455"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kato T, Honda Y, Kurita Y, Iwasaki A, Sato T,          Kessoku T, Uchiyama S, Ogawa Y, Ohkubo H, Higurashi T, Yamanaka T, Usuda H, Wada K,          Nakajima A: Lubiprostone improves intestinal permeability in humans, a novel therapy for          the leaky gut: a prospective randomized pilot study in healthy volunteers. PLoS One 2017;          12: e0175626. PMID:28410406 https:\/\/doi.org\/10.1371\/journal.pone.0175626","DOI":"10.1371\/journal.pone.0175626"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Castro J, Harrington AM, Hughes PA, Martin CM, Ge          P, Shea CM, Jin H, Jacobson S, Hannig G, Mann E, Cohen MB, MacDougall JE, Lavins BJ, Kurtz          CB, Silos-Santiago I, Johnston JM, Currie MG, Blackshaw LA, Brierley SM: Linaclotide          inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and          extracellular cyclic guanosine 3\u2032,5\u2032-monophosphate. Gastroenterology. 2013;145: 1334\u20131346.          PMID:29278278 https:\/\/doi.org\/10.1111\/nmo.13275","DOI":"10.1053\/j.gastro.2013.08.017"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Fukudo S, Nakajima A, Fujiyama Y, Kosako M,          Nakagawa A, Akiho H, Nakashima Y, Johnston JM, Miwa H: Determining an optimal dose of          linaclotide for use in Japanese patients with irritable bowel syndrome with constipation:          a phase II randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil          2018; 30: e13275. PMID:29278278 https:\/\/doi.org\/10.1111\/nmo.13275","DOI":"10.1111\/nmo.13363"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Fukudo S, Miwa H, Nakajima A, Kinoshita Y, Kosako          M, Nakagawa A, Akiho H, Kuroishi K, Johnston JM, Currie M, Ohkusa T: Dose-finding study of          linaclotide in Japanese patients with chronic constipation: a phase II randomized,          double-blind, and placebo-controlled study. Neurogastroenterol Motil 2018; 30: e13442.          PMID:30084233 https:\/\/doi.org\/10.1111\/nmo.13442","DOI":"10.1111\/nmo.13442"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Fukudo S, Miwa H, Nakajima A, Kinoshita Y, Kosako          M, Hayashi K, Akiho H, Kuroishi K, Johnston JM, Currie M, Ohkusa T: High\u2010dose linaclotide          is effective and safe in patients with chronic constipation: a phase III randomized,          double\u2010blind, placebo\u2010controlled study with a long\u2010term open\u2010label extension study in          Japan. Neurogastroenterol Motil 2019; 31: e13487. PMID:30353619          https:\/\/doi.org\/10.1111\/nmo.13487","DOI":"10.1111\/nmo.13487"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Markham A: Naldemedine: first global approval.          Drugs 2017; 77: 923\u2013927. PMID:28466424          https:\/\/doi.org\/10.1007\/s40265-017-0750-0","DOI":"10.1007\/s40265-017-0750-0"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Katakami N, Oda K, Tauchi K, Nakata K, Shinozaki          K, Yokota T, Suzuki Y, Narabayashi M, Boku N: Phase IIb, randomized, double-blind,          placebo-controlled study of naldemedine for the treatment of opioid-induced constipation          in patients with cancer. J Clin Oncol 2017; 35: 1921\u20131928. PMID:28445097          https:\/\/doi.org\/10.1200\/JCO.2016.70.8453","DOI":"10.1200\/JCO.2016.70.8453"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Nakajima A, Seki M, Taniguchi S: Determining an          optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter,          in Japanese patients with chronic constipation: a phase II, multicenter, double-blind,          placebo-controlled randomized clinical trial. J Gastroenterol 2018; 53: 525\u2013534.          PMID:28840422 https:\/\/doi.org\/10.1007\/s00535-017-1383-5","DOI":"10.1007\/s00535-017-1383-5"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Nakajima A, Fujimaki M, Arai Y, Emori K: Safety          and efficacy of elobixibat, an ileal bile acid transporter inhibitor, in elderly patients          with chronic idiopathic constipation according to administration time: interim analysis of          post-marketing surveillance. J Neurogastroenterol Motil 2022; 28: 431\u2013441. PMID:35799237          https:\/\/doi.org\/10.5056\/jnm20263","DOI":"10.5056\/jnm20263"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Nagata K, Endo S, Ichikawa T, Dasai K, Moriya K,          Kushihashi T, Kudo S: Polyethylene glycol solution (PEG) plus contrast medium vs PEG alone          preparation for CT colonography and conventional colonoscopy in preoperative colorectal          cancer staging. Int J Colorectal Dis 2006; 22: 69\u201376. PMID:16583194          https:\/\/doi.org\/10.1007\/s00384-006-0113-x","DOI":"10.1007\/s00384-006-0113-x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Nakajima A, Shinbo K, Oota A, Kinoshita Y:          Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized,          double-blind, placebo-controlled study with a 52-week open-label extension. J          Gastroenterol 2019; 54: 792\u2013803. PMID:31011797          https:\/\/doi.org\/10.1007\/s00535-019-01581-x","DOI":"10.1007\/s00535-019-01581-x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kasugai K, Iwai H, Kuboyama N, Yoshikawa A,          Fukudo S: Efficacy and safety of a crystalline lactulose preparation (SK-1202) in Japanese          patients with chronic constipation: a randomized, double-blind, placebo-controlled,          dose-finding study. J Gastroenterol 2019; 54: 530\u2013540. PMID:30643982          https:\/\/doi.org\/10.1007\/s00535-018-01545-7","DOI":"10.1007\/s00535-018-01545-7"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Zhang Y, Yin F, Xu L, Li Y, Chen J, Liu H, Zheng          Q, Li L: Comparative efficacy of drugs for the treatment of chronic constipation:          quantitative information for medication guidelines. J Clin Gastroenterol 2020; 54:          e93\u2013e102. PMID:31904680 https:\/\/doi.org\/10.1097\/MCG.0000000000001303","DOI":"10.1097\/MCG.0000000000001303"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Nelson AD, Camilleri M, Chirapongsathorn S,          Vijayvargiya P, Valentin N, Shin A, Erwin PJ, Wang Z, Murad MH: Comparison of efficacy of          pharmacological treatments for chronic idiopathic constipation: a systematic review and          network meta-analysis. Gut 2017; 66: 1611\u20131622. PMID:27287486          https:\/\/doi.org\/10.1136\/gutjnl-2016-311835","DOI":"10.1136\/gutjnl-2016-311835"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Nakajima A, Shoji A, Kokubo K, Igarashi A: A          systematic review and network meta-analysis on the efficacy of medications in the          treatment of chronic idiopathic constipation in Japan. Gastroenterol Res Pract 2021; 2021:          1\u201313. PMID:34887919 https:\/\/doi.org\/10.1155\/2021\/5534687","DOI":"10.1155\/2021\/5534687"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/72\/4\/72_2022-0036-IR\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:16:43Z","timestamp":1715577403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/72\/4\/72_2022-0036-IR\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2022-0036-ir","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"2022-0036-IR"}}